As US policymakers debate federal budget cuts, global health science hangs in the balance.
The Scientist
Most Recent
The method to the dengue virus's maddening infectiousness.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Agencies like the NSF and NIH are losing around 5 percent of their yearly budgets.
The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
A new project to map the activity of the human brain could receive more than $3 billion dollars in federal funds in President Obama’s upcoming budget proposal.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Engineer and materials scientist Subra Suresh will become president of Carnegie Mellon University.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
